Filing Details

Accession Number:
0001567619-20-015711
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-18 17:09:58
Reporting Period:
2020-08-14
Accepted Time:
2020-08-18 17:09:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1800619 Nimrata Hunt Idexx Laboratories, Inc.
One Idexx Drive
Westbrook ME 04092
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-08-14 2,676 $377.50 7,947 No 4 S Direct
Common Stock Disposition 2020-08-14 100 $377.51 7,847 No 4 S Direct
Common Stock Acquisiton 2020-08-18 698 $79.54 8,545 No 4 M Direct
Common Stock Acquisiton 2020-08-18 1,107 $67.85 9,652 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right-to-buy) Disposition 2020-08-18 698 $0.00 698 $79.54
Common Stock Incentive Stock Option (right-to-buy) Disposition 2020-08-18 1,107 $0.00 1,107 $67.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-02-13 No 4 M Direct
769 2026-02-13 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 160 Indirect jointly with spouse
Footnotes
  1. Includes a total of 38 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2020 and June 30, 2020.
  2. Grant of option to buy 1,366 shares of Issuer common stock that vests in five annual installments beginning on February 14, 2016. The number of derivative securities reported as beneficially owned and price with respect to this option were adjusted to reflect a 2-for-1 stock split in the form of a 100% stock dividend on IDEXX Laboratories, Inc. common stock paid on June 15, 2015.
  3. Grant of option to buy 1,906 shares of Issuer common stock that vests as to 1 share on February 14, 2017, 29 shares on February 14, 2018, 365 shares on February 14, 2019, 742 shares on February 14, 2020 and as to the remainder on February 14, 2021.
  4. Not applicable.